Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Basic Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to GlaxoSmithKline Intellectual Property Development Limted
Patents Assigned to GlaxoSmithKline Intellectual Property Development Limted
Quinazolines as kinase inhibitors
Patent number:
9650364
Abstract:
Disclosed are compounds that are inhibitors of RIP2 kinase and methods of making and using the same.
Type:
Grant
Filed:
February 19, 2014
Date of Patent:
May 16, 2017
Assignee:
GlaxoSmithKline Intellectual Property Development Limted
Inventors:
Linda N. Casillas, Adam Kenneth Charnley, Xiaoyang Dong, Pamela A. Haile, Michael P. Demartino, John F. Mehlmann